Kyung Nam Pharm Co Ltd (053950) — Cash Flow-to-Debt Ratio
Kyung Nam Pharm Co Ltd (053950) has a Cash Flow-to-Debt Ratio of -0.06x as of March 2026, meaning its operating cash flow of ₩-2.84 Billion could theoretically repay 0% of its total liabilities (₩50.62 Billion) in one year. Check cash flow reinvestment rate of Kyung Nam Pharm Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kyung Nam Pharm Co Ltd Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Kyung Nam Pharm Co Ltd across 10 annual periods. Also explore 053950 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Kyung Nam Pharm Co Ltd (2007–2025)
Year-by-year debt coverage analysis for Kyung Nam Pharm Co Ltd. For market capitalisation and broader financial context, see Kyung Nam Pharm Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.04x | ₩-1.68 Billion | ₩47.33 Billion | ▼ -199.3% |
| 2024 | 0.04x | ₩1.84 Billion | ₩51.36 Billion | ▲ +296.4% |
| 2023 | 0.01x | ₩693.30 Million | ₩76.78 Billion | ▲ +461.4% |
| 2022 | 0.00x | ₩71.58 Million | ₩44.50 Billion | ▼ -95.7% |
| 2020 | 0.04x | ₩2.62 Billion | ₩69.29 Billion | ▲ +107.8% |
| 2019 | -0.48x | ₩-6.43 Billion | ₩13.27 Billion | ▼ -569.3% |
| 2018 | -0.07x | ₩-1.75 Billion | ₩24.24 Billion | ▼ -142.0% |
| 2016 | 0.17x | ₩4.89 Billion | ₩28.35 Billion | ▲ +2301.3% |
| 2010 | 0.01x | ₩482.65 Million | ₩67.22 Billion | ▲ +52.2% |
| 2007 | 0.00x | ₩148.79 Million | ₩31.55 Billion | — |